Oxbow Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.11M | Buy |
24,293
+819
| +3% | +$176K | 0.5% | 55 |
|
|
2026
Q1 | $5.11M | Buy |
23,474
+352
| +2% | +$78.1K | 0.43% | 63 |
|
|
2025
Q4 | $5.28M | Sell |
23,122
-200
| -0.9% | -$45.6K | 0.46% | 62 |
|
|
2025
Q3 | $5.4M | Buy |
23,322
+335
| +1% | +$68.2K | 0.5% | 55 |
|
|
2025
Q2 | $4.27M | Buy |
22,987
+15,967
| +227% | +$2.97M | 0.47% | 60 |
|
|
2025
Q1 | $1.47M | Sell |
7,020
-100
| -1% | -$19.4K | 0.16% | 99 |
|
|
2024
Q4 | $1.27M | Buy |
7,120
+88
| +1% | +$16.2K | 0.15% | 104 |
|
|
2024
Q3 | $1.39M | Sell |
7,032
-327
| -4% | -$61K | 0.14% | 98 |
|
|
2024
Q2 | $1.26M | Hold |
7,359
| – | – | 0.15% | 91 |
|
|
2024
Q1 | $1.34M | Buy |
7,359
+294
| +4% | +$50.7K | 0.18% | 77 |
|
|
2023
Q4 | $1.09M | Sell |
7,065
-517
| -7% | -$75.4K | 0.17% | 77 |
|
|
2023
Q3 | $1.13M | Buy |
7,582
+1,212
| +19% | +$178K | 0.18% | 73 |
|
|
2023
Q2 | $858K | Sell |
6,370
-90
| -1% | -$13.2K | 0.13% | 92 |
|
|
2023
Q1 | $1.03M | Sell |
6,460
-51
| -0.8% | -$7.8K | 0.18% | 78 |
|
|
2022
Q4 | $1.05M | Sell |
6,511
-104
| -2% | -$15.9K | 0.2% | 76 |
|
|
2022
Q3 | $888K | Buy |
6,615
+213
| +3% | +$30.6K | 0.14% | 105 |
|
|
2022
Q2 | $981K | Buy |
6,402
+181
| +3% | +$27.7K | 0.14% | 102 |
|
|
2022
Q1 | $1.01M | Sell |
6,221
-2,679
| -30% | -$389K | 0.1% | 118 |
|
|
2021
Q4 | $1.21M | Sell |
8,900
-70
| -0.8% | -$8.27K | 0.12% | 115 |
|
|
2021
Q3 | $968K | Sell |
8,970
-18
| -0.2% | -$2.06K | 0.1% | 140 |
|
|
2021
Q2 | $1.01M | Buy |
8,988
+18
| +0.2% | +$2.03K | 0.11% | 137 |
|
|
2021
Q1 | $971K | Sell |
8,970
-2,165
| -19% | -$232K | 0.12% | 131 |
|
|
2020
Q4 | $1.19M | Buy |
11,135
+375
| +3% | +$36K | 0.15% | 108 |
|
|
2020
Q3 | $942K | Buy |
10,760
+1,190
| +12% | +$112K | 0.12% | 131 |
|
|
2020
Q2 | $940K | Sell |
9,570
-1,277
| -12% | -$112K | 0.14% | 129 |
|
|
2020
Q1 | $826K | Sell |
10,847
-45
| -0.4% | -$3.83K | 0.14% | 132 |
|
|
2019
Q4 | $964K | Sell |
10,892
-2,130
| -16% | -$177K | 0.11% | 153 |
|
|
2019
Q3 | $986K | Sell |
13,022
-97,337
| -88% | -$6.67M | 0.13% | 145 |
|
|
2019
Q2 | $8.03M | Buy |
110,359
+29,771
| +37% | +$2.34M | 0.97% | 21 |
|
|
2019
Q1 | $6.5M | Sell |
80,588
-2,742
| -3% | -$224K | 0.79% | 25 |
|
|
2018
Q4 | $7.68M | Buy |
83,330
+14,004
| +20% | +$1.23M | 1.03% | 22 |
|
|
2018
Q3 | $6.56M | Buy |
69,326
+3,090
| +5% | +$293K | 0.79% | 33 |
|
|
2018
Q2 | $6.14M | Sell |
66,236
-2,402
| -3% | -$235K | 0.78% | 32 |
|
|
2018
Q1 | $6.5M | Sell |
68,638
-10,433
| -13% | -$1.15M | 1.32% | 16 |
|
|
2017
Q4 | $7.65M | Sell |
79,071
-1,742
| -2% | -$164K | 1.43% | 14 |
|
|
2017
Q3 | $7.18M | Sell |
80,813
-6,273
| -7% | -$478K | 1.37% | 16 |
|
|
2017
Q2 | $6.32M | Sell |
87,086
-410
| -0.5% | -$27.6K | 1.12% | 20 |
|
|
2017
Q1 | $5.7M | Buy |
87,496
+447
| +0.5% | +$28.1K | 0.93% | 29 |
|
|
2016
Q4 | $5.45M | Sell |
87,049
-1,898
| -2% | -$116K | 0.68% | 39 |
|
|
2016
Q3 | $5.61M | Sell |
88,947
-1,168
| -1% | -$75.6K | 0.77% | 36 |
|
|
2016
Q2 | $5.58M | Sell |
90,115
-1,143
| -1% | -$69.6K | 0.8% | 34 |
|
|
2016
Q1 | $5.21M | Sell |
91,258
-1,568
| -2% | -$87.4K | 0.74% | 41 |
|
|
2015
Q4 | $5.5M | Buy |
92,826
+84,967
| +1,081% | +$4.89M | 0.69% | 41 |
|
|
2015
Q3 | $427K | Buy |
7,859
+662
| +9% | +$43.1K | 0.07% | 176 |
|
|
2015
Q2 | $484K | Buy |
7,197
+209
| +3% | +$13.6K | 0.06% | 181 |
|
|
2015
Q1 | $409K | Buy |
6,988
+2
| +0% | +$121 | 0.06% | 148 |
|
|
2014
Q4 | $457K | Sell |
6,986
-399
| -5% | -$25.2K | 0.06% | 144 |
|
|
2014
Q3 | $427K | Buy |
7,385
+200
| +3% | +$11.1K | 0.06% | 154 |
|
|
2014
Q2 | $406K | Hold |
7,185
| – | – | 0.05% | 157 |
|
|
2014
Q1 | $369K | Hold |
7,185
| – | – | 0.05% | 167 |
|
|
2013
Q4 | $379K | Hold |
7,185
| – | – | 0.05% | 168 |
|
|
2013
Q3 | $321K | Hold |
7,185
| – | – | 0.05% | 167 |
|
|
2013
Q2 | $297K | Buy |
+7,185
| New | +$314K | 0.05% | 157 |
|
Other funds holding ABBV
Oxbow Advisors's ABBV Position: Q2 2026 in Review
Oxbow Advisors increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $176K and bringing the position to 24,293 shares worth $6.11M. The position accounts for 0.5% of the portfolio, ranked #55.
Oxbow Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.03M in Q2 2019. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Oxbow Advisors held 24,293 shares of AbbVie worth $6.11M as of Q2 2026.
- Oxbow Advisors bought 819 AbbVie shares in Q2 2026, an estimated $176K.
- AbbVie made up 0.5% of Oxbow Advisors's portfolio in Q2 2026, its #55 holding.
- Oxbow Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Oxbow Advisors's AbbVie position peaked at $8.03M in Q2 2019.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.